The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions
Breast cancer (BC) in elderly women is an increasing health issue due to demographic changes. BC tends to present later and may receive less than standard treatment options. More often, BC in elderly patients is endocrine-positive (HR+). The treatment of elderly patients with metastatic BC (mBC) rep...
Main Authors: | Carmelo Laface, Francesco Giuliani, Assunta Melaccio, Maria Nicla Pappagallo, Anna Natalizia Santoro, Martina Perrone, Pierluigi De Santis, Chiara Guarini, Daniela Carrozzo, Palma Fedele |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/18/6012 |
Similar Items
-
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
by: Felicia Maria Maselli, et al.
Published: (2023-06-01) -
Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response
by: Pierluigi De Santis, et al.
Published: (2024-02-01) -
Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?
by: Pierluigi De Santis, et al.
Published: (2023-11-01) -
The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies
by: Carmelo Laface, et al.
Published: (2023-05-01) -
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
by: Carmelo Laface, et al.
Published: (2023-06-01)